Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reiter

Showing results (341-350 of 386) with videos related to

Pageof 39
Sort By:
European Urology Oncology|February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional ImagingTing Martin Ma, Andrei Gafita, David Shabsovich, et al.
European Urology|September 20, 2024
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) ConsortiumWee Loon Ong, Tahmineh Romero, Soumyajit Roy, et al.
European Urology|July 23, 2023
Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging TrialLoïc Djaïleb, Wesley R Armstrong, Daniel Thompson, et al.
European Urology|October 1, 2025
Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical TrialAmar U Kishan, Jesus E Juarez Casillas, Paul Sargos, et al.
Nature Medicine|June 12, 2024
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trialTanya B Dorff, M Suzette Blanchard, Lauren N Adkins, et al.
Cell Reports|October 10, 2023
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancerPreston D Crowell, Jenna M Giafaglione, Anthony E Jones, et al.
Cancer Research|September 4, 2014
Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imagingNathan S White, Carrie McDonald, Carrie R McDonald, et al.
European Urology|November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.
European Urology|April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate CancerWilliam S Chen, Rahul Aggarwal, Li Zhang, et al.
Cancer Research|June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate CancerArian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Pageof 39

Showing results (341-350 of 386) with videos related to

Sort By:
Pageof 39
European Urology Oncology|February 19, 2021
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional ImagingTing Martin Ma, Andrei Gafita, David Shabsovich, et al.
European Urology|September 20, 2024
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) ConsortiumWee Loon Ong, Tahmineh Romero, Soumyajit Roy, et al.
European Urology|July 23, 2023
Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging TrialLoïc Djaïleb, Wesley R Armstrong, Daniel Thompson, et al.
European Urology|October 1, 2025
Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical TrialAmar U Kishan, Jesus E Juarez Casillas, Paul Sargos, et al.
Nature Medicine|June 12, 2024
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trialTanya B Dorff, M Suzette Blanchard, Lauren N Adkins, et al.
Cell Reports|October 10, 2023
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancerPreston D Crowell, Jenna M Giafaglione, Anthony E Jones, et al.
Cancer Research|September 4, 2014
Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imagingNathan S White, Carrie McDonald, Carrie R McDonald, et al.
European Urology|November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.
European Urology|April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate CancerWilliam S Chen, Rahul Aggarwal, Li Zhang, et al.
Cancer Research|June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate CancerArian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Pageof 39